Terms: = Bone cancer AND RHOA, ENSG00000067560, 387, ARHA, RhoA, RHOH12, RHO12, ARH12, Rho12 AND Staging
5 results:
1. Development and validation of a novel model to predict recurrence-free survival and melanoma-specific survival after sentinel lymph node biopsy in patients with melanoma: an international, retrospective, multicentre analysis.
Stassen RC; Maas CCHM; van der Veldt AAM; Lo SN; Saw RPM; Varey AHR; Scolyer RA; Long GV; Thompson JF; Rutkowski P; Keilholz U; van Akkooi ACJ; Verhoef C; van Klaveren D; Grünhagen DJ
Lancet Oncol; 2024 Apr; 25(4):509-517. PubMed ID: 38547894
[TBL] [Abstract] [Full Text] [Related]
2. Identification of clinical implications and potential prognostic models of chromatin regulator mutations in multiple myeloma.
Zhang L; Zhang R; Wang J; Chen Y; Qiao C; Shi Q; Jin Y; Shen X; Li J; Chen L
Clin Epigenetics; 2022 Jul; 14(1):93. PubMed ID: 35870987
[TBL] [Abstract] [Full Text] [Related]
3. Do predetermined surgical margins compromise oncological safety in computer-assisted head and neck reconstruction?
Pu JJ; Choi WS; Yu P; Wong MCM; Lo AWI; Su YX
Oral Oncol; 2020 Dec; 111():104914. PubMed ID: 32712577
[TBL] [Abstract] [Full Text] [Related]
4. [Value of (99)Tc(m)-MDP SPECT/CT in clinical decision-making for nasopharyngeal carcinoma and a comparison of the values of different imaging techniques for diagnosing skull-base bone invasion].
Li W; Zhang RS; Zhang LQ; Lu BG; Fu WH
Zhonghua Zhong Liu Za Zhi; 2017 Feb; 39(2):133-137. PubMed ID: 28219209
[No Abstract] [Full Text] [Related]
5. FDG uptake by the bone marrow in NSCLC patients is related to TGF-beta but not to VEGF or G-CSF serum levels.
Van de Wiele C; VandeVyver F; Debruyne C; Philippé J; van Meerbeeck JP
Eur J Nucl Med Mol Imaging; 2008 Mar; 35(3):519-22. PubMed ID: 18034241
[TBL] [Abstract] [Full Text] [Related]
